Tri Locum Partners »

Vertex Pharmaceuticals Incorporated shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 36k 418.01
2023-06-30 $8.7M 25k 351.91

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Silk Road Medical Inc Common (SILK)
Natera (NTRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Legend Biotech Corp Sponsored Ads (LEGN)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Madrigal Pharmaceuticals (MDGL)
Baxter International (BAX)
Merus N V (MRUS)
Tandem Diabetes Care Com New (TNDM)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Regeneron Pharmaceuticals (REGN)

View all positions for Tri Locum Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated